Navigated to Renlo Health: GLP-1 Costs, Billing and Commitment
Skip to main content
GLP1 Buyer Guide
All ranked programsProvider profile
Compounded products2 recorded medications

Renlo Health

Renlo Health is recorded on 2 offers in this comparison, covering semaglutide, tirzepatide. Each plan is recorded separately with its own charge, cadence and commitment.

By Open Water Rx Editorial Team, Publisher and buyer-guide research

Price sources checked
Buyer Guide ScoreMethod
72.5/100
Strong

Ranked 42 of 67 programs in the buyer guide index.

Price100/100
Fee transparency50/100
Cadence certainty100/100
Terms on record100/100

Each criterion is rated on its own out of 100. The headline score is the publisher’s overall judgment; it is not an average of these four readings.

Tirzepatide
$199Recorded plan charge
Semaglutide
$149Recorded plan charge
Membership
Not statedNot stated on the provider page
Commitment
Auto-renewsThe term recorded on the plan

Supported tradeoffs

Monthly price profile only. The published refund guarantee excludes certain medical discontinuations and requires a request within 14 days after the four-month mark; do not imply all unsuccessful treatment is refunded.

Billing and cancellation

Semaglutide is $149 and tirzepatide $199 per month, with the same advertised price at each prescribed dose.

Availability

The supported-state list is not established for this program, so the field is left blank rather than assumed.

Availability is set program by program by prescriber licensure, pharmacy fulfillment and state rules, so it can change after a directory is published. A provider state directory is not a fulfillment guarantee, and where a supported-state list is not established the field is left blank rather than assumed.

Offer terms in detail

Every field the record carries for each plan, with the date the provider page behind it was checked.

SemaglutideCompounded · not FDA-approved

1-month plan

5 recorded source entries · last checked October 22, 2026.

Recurring charge

$149

Recurring

Formulation
Compounded injectable
Initial payment
$149 · After a provider reviews and approves treatment; any charge for a declined initial evaluation is refunded.
Billing cadence
Recurring
Supply period
Not established from reviewed sources.
Commitment
Auto-renews on the recorded billing cadence until canceled. Each charge covers 1 month as published. The minimum term is not established from the reviewed terms; the cancellation conditions are recorded on this offer.
Required fees
No standard extra fees are recorded. Conditional: Outside care and third-party costs are separate. No standard membership or consultation fee is advertised.
Conditional fees
Outside care and third-party costs are separate. No standard membership or consultation fee is advertised.
Inclusions
Provider consultation, prescribed medication, injection supplies, shipping and ongoing care-team messaging.
Dose scope
Same advertised price at every prescribed dose
Eligibility
Subject to provider approval and availability
Cancellation
Pause or cancel before the next shipment ships, with no cancellation fee. Contact the care team; the reviewed offer does not specify a separate numerical advance-notice period.
Refunds
No charge or full refund if initially not prescribed. Otherwise paid services are generally nonrefundable. A separate four-month outcome refund has eligibility, uninterrupted-treatment and weight-verification conditions and is not an unconditional refund or clinical-results promise.
Limitations
Monthly price profile only. The published refund guarantee excludes certain medical discontinuations and requires a request within 14 days after the four-month mark; do not imply all unsuccessful treatment is refunded.
Offers excluded from this release
[]
Verification
published price and billing terms · recheck due October 29, 2026
TirzepatideCompounded · not FDA-approved

1-month plan

5 recorded source entries · last checked October 22, 2026.

Recurring charge

$199

Recurring

Formulation
Compounded injectable
Initial payment
$199 · After a provider reviews and approves treatment; any charge for a declined initial evaluation is refunded.
Billing cadence
Recurring
Supply period
Not established from reviewed sources.
Commitment
Auto-renews on the recorded billing cadence until canceled. Each charge covers 1 month as published. The minimum term is not established from the reviewed terms; the cancellation conditions are recorded on this offer.
Required fees
No standard extra fees are recorded. Conditional: Outside care and third-party costs are separate. No standard membership or consultation fee is advertised.
Conditional fees
Outside care and third-party costs are separate. No standard membership or consultation fee is advertised.
Inclusions
Provider consultation, prescribed medication, injection supplies, shipping and ongoing care-team messaging.
Dose scope
Same advertised price at every prescribed dose
Eligibility
Subject to provider approval and availability
Cancellation
Pause or cancel before the next shipment ships, with no cancellation fee. Contact the care team; the reviewed offer does not specify a separate numerical advance-notice period.
Refunds
No charge or full refund if initially not prescribed. Otherwise paid services are generally nonrefundable. A separate four-month outcome refund has eligibility, uninterrupted-treatment and weight-verification conditions and is not an unconditional refund or clinical-results promise.
Verification
published price and billing terms · recheck due October 29, 2026

Cost and verification scope

Semaglutide · Tirzepatide

Published standard plan bundle; conditional charges are described in provider terms

Published pricing and billing terms; no purchase, clinical, licensing or fulfillment audit

Last checked

Most recent check date

October 22, 2026

The newest date we checked Renlo Health's own published pages. A figure we could not check carries no date rather than an unverified one, and this research reads published pages, not checkout transactions.

How sources are checked

Every recorded offer, side by side with the others: the comparison ledger.

Back to the provider directory
FAQ

Questions about Renlo Health

How to read the fields, the sources and the labels on this profile.

  • It means no reliable figure exists yet for that field on this provider, so we leave it blank instead of guessing. A field becomes a published value only when a page on this provider supports it.

Last modified . Facts carry the date we checked the provider page behind them.